Study of novel anticancer 4-thiazolidinone derivatives
- 1 January 2017
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 262, 46-56
Abstract
No abstract availableKeywords
Funding Information
- statutory funds of the University of Information Technology and Management in Rzeszow, Poland (DS 503-07-02-21)
This publication has 51 references indexed in Scilit:
- Fused Thiopyrano[2,3-d]thiazole Derivatives as Potential Anticancer AgentsScientia Pharmaceutica, 2012
- Isorhodanine and Thiorhodanine Motifs in the Synthesis of Fused Thiopyrano[2,3-d][1,3]thiazolesSynlett, 2011
- Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific groupBiopolymers and Cell, 2011
- A Facile Synthesis and Anticancer Activity Evaluation of Spiro[Thiazolidinone-Isatin] ConjugatesScientia Pharmaceutica, 2011
- Nrf2 signaling and cell survivalToxicology and Applied Pharmacology, 2010
- Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivativesEuropean Journal of Medicinal Chemistry, 2009
- HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cellsMolecular Cancer Therapeutics, 2009
- Modulation of cell growth and PPARγ expression in human colorectal cancer cell lines by ciglitazoneExperimental and Toxicologic Pathology, 2008
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Differential effects of PPARγ agonists on the metabolic properties of gliomas and astrocytesNeuroscience Letters, 2007